Patents by Inventor Max Spielberg

Max Spielberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID PHARMACEUTICAL TABLET
    Publication number: 20240130985
    Abstract: A tablet includes an active material and a base material that carnauba wax and an oil.
    Type: Application
    Filed: October 18, 2022
    Publication date: April 25, 2024
    Inventors: Max Spielberg, David Johnson
  • SOLID PHARMACEUTICAL TABLET
    Publication number: 20240130974
    Abstract: A solid tablet includes an active material and a base material that gum, rice bran, rice hull, carbonate, carnauba wax, and maltodextrin and an edible oil.
    Type: Application
    Filed: November 18, 2022
    Publication date: April 25, 2024
    Inventors: Max Spielberg, David Johnson
  • Dextromethorphan and guaifenesin syrup formulation or suspension
    Patent number: 11931413
    Abstract: A stable pharmaceutical formulation or suspension has a pharmaceutical active agent, agave, and a dilutant. The formulation or suspension has viscosity suitable for drinking.
    Type: Grant
    Filed: August 19, 2022
    Date of Patent: March 19, 2024
    Inventors: Max Spielberg, David Johnson
  • SYRUP FORMULATION OR SUSPENSION
    Publication number: 20230321248
    Abstract: A stable pharmaceutical formulation or suspension has acetaminophen, a suspension agent, and a diluent. The formulation or suspension has viscosity suitable for drinking.
    Type: Application
    Filed: May 24, 2023
    Publication date: October 12, 2023
    Inventors: Max Spielberg, David Johnson
  • DIPHENHYDRAMINE SYRUP FORMULATION OR SUSPENSION
    Publication number: 20230165963
    Abstract: A stable pharmaceutical formulation or suspension has a pharmaceutical active agent, agave, and a dilutant. The formulation or suspension has viscosity suitable for drinking.
    Type: Application
    Filed: August 19, 2022
    Publication date: June 1, 2023
    Inventors: Max Spielberg, David Johnson
  • Pharmaceutical syrup formulation or suspension
    Patent number: 11617795
    Abstract: A stable pharmaceutical formulation or suspension has a pharmaceutical active agent, agave, and a dilutant. The formulation or suspension has viscosity suitable for drinking.
    Type: Grant
    Filed: August 4, 2022
    Date of Patent: April 4, 2023
    Assignee: Genexa Inc.
    Inventors: Max Spielberg, David Johnson
  • PHARMACEUTICAL SYRUP FORMULATION OR SUSPENSION
    Publication number: 20230071165
    Abstract: A stable pharmaceutical formulation or suspension has a pharmaceutical active agent, agave, and a dilutant. The formulation or suspension has viscosity suitable for drinking.
    Type: Application
    Filed: August 4, 2022
    Publication date: March 9, 2023
    Inventors: Max Spielberg, David Johnson
  • DEXTROMETHORPHAN AND GUAIFENESIN SYRUP FORMULATION OR SUSPENSION
    Publication number: 20220387598
    Abstract: A stable pharmaceutical formulation or suspension has a pharmaceutical active agent, agave, and a dilutant. The formulation or suspension has viscosity suitable for drinking.
    Type: Application
    Filed: August 19, 2022
    Publication date: December 8, 2022
    Inventors: Max Spielberg, David Johnson
  • CHEWABLE TABLET
    Publication number: 20220040097
    Abstract: A chewable tablet formulation includes an active material comprising an active agent in a maltodextrin base and an inactive material comprising a sugar, rice bran, carnauba wax, maltodextrin and a flavoring agent.
    Type: Application
    Filed: October 21, 2021
    Publication date: February 10, 2022
    Inventors: Max Spielberg, David Johnson
  • PHARMACEUTICAL SYRUP FORMULATION OR SUSPENSION
    Publication number: 20210290532
    Abstract: A stable pharmaceutical formulation or suspension has a pharmaceutical active agent, agave, and a dilutant. The formulation or suspension has viscosity suitable for drinking.
    Type: Application
    Filed: June 8, 2021
    Publication date: September 23, 2021
    Inventors: Max Spielberg, David Johnson
  • Stable liquid formulations for pharmaceuticals and supplements
    Publication number: 20200338200
    Abstract: A liquid composition comprising: a primary component being an Active Pharmaceutical Ingredient (API), a nutritional supplement, or combinations thereof: a base; and a preservative blend is provided along with a method of making said composition.
    Type: Application
    Filed: March 23, 2020
    Publication date: October 29, 2020
    Inventors: Max Spielberg, David Johnson
  • Stable liquid formulations for pharmaceuticals and supplements comprising an herbal mixture
    Patent number: 10596266
    Abstract: A liquid composition comprising: a primary component being an Active Pharmaceutical Ingredient (API), a nutritional supplement, or combinations thereof: a base; and a preservative blend is provided along with a method of making said composition.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: March 24, 2020
    Inventors: Max Spielberg, David Johnson
  • Organic nasal treatment solution
    Patent number: 10596105
    Abstract: A nasal spray or therapy solution is provided having organic glycerin; an organic preservative system containing glycerin, citrus reticulata fruit extract, citrus aurantium amara fruit extract, citrus aurantium sinensis peel extract, ascorbic acid, citric acid, lactic acid, water; sodium chloride; water; whereby said nasal spray exhibits inhibited bacteriological growth in vitro for up to 36 months.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: March 24, 2020
    Inventors: Max Spielberg, David Johnson
  • STABLE FORMULATIONS FOR CREAM
    Publication number: 20200022907
    Abstract: The present invention is an organic roll-on pain formulation including Menthol—ethyl alcohol component premixed in a ratio of menthol: ethyl alcohol 1-6.0-8.0 along with a a carrier - preservative system consisting of components in a ratio of Glycerin: Aloe Vera Leaf Juice: Licorice Root Extract: Peppermint Oil: Xanthan Gum in a ratio of 1:0.3-0.4:0.006-0.007:0.3-0.4:0.10-0.15 each combined in water.
    Type: Application
    Filed: July 20, 2018
    Publication date: January 23, 2020
    Inventors: Max Spielberg, David Johnson
  • ORGANIC TABLET FORMULATION
    Publication number: 20190388353
    Abstract: A chewable tablet includes: an active ingredient combined with organic dextrose, organic Nu Rice Bran, organic Acai Berry, organic carnauba wax, organic maltodextrin.
    Type: Application
    Filed: June 21, 2018
    Publication date: December 26, 2019
    Inventors: Max Spielberg, David Johnson
  • STABLE LIQUID FORMULATIONS FOR PHARMACEUTICALS AND SUPPLEMETNTS
    Publication number: 20190125881
    Abstract: A liquid composition comprising: a primary component being an Active Pharmaceutical Ingredient (API), a nutritional supplement, or combinations thereof: a base; and a preservative blend is provided along with a method of making said composition.
    Type: Application
    Filed: March 6, 2018
    Publication date: May 2, 2019
    Inventors: MAX SPIELBERG, DAVID JOHNSON
  • ORGANIC NASAL TREATMENT SOLUTION
    Publication number: 20190000752
    Abstract: A nasal spray or therapy solution is provided having organic glycerin; an organic preservative system containing glycerin, citrus reticulata fruit extract, citrus aurantium amara fruit extract, citrus aurantium sinensis peel extract, ascorbic acid, citric acid, lactic acid, water; sodium chloride; water; whereby said nasal spray exhibits inhibited bacteriological growth in vitro for up to 36 months.
    Type: Application
    Filed: March 6, 2018
    Publication date: January 3, 2019
    Inventors: Max Spielberg, David Johnson